• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. TYRX ABSORBABLE ANTIBACTERIAL ENVELOPE; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. TYRX ABSORBABLE ANTIBACTERIAL ENVELOPE; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number CMRM6122
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Abscess (1690); Erythema (1840); Fever (1858); Pain (1994); Swelling/ Edema (4577); Medical device site infection (4845)
Date of Event 02/04/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Continuation of d10: 429878 lead implanted (b)(6) 2015; dtpa2q1 crt-d implanted (b)(6) 2024 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that the patient presented approximately two and a half months post-generator replacement procedure with use of an antibacterial absorbable envelope.The skin above the cardiac resynchronization therapy defibrillator (crt-d) was red, purple, swollen, painful, warm to the touch with possible abscess, with redness extending around the device towards the neck, and the patient had a fever.The patient was admitted for administration of intravenous antibiotics.The patient was transferred to a higher care facility the following week.The system was removed due to pocket infection. the patient is a participant in a clinical study.  no further patient complications have been reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TYRX ABSORBABLE ANTIBACTERIAL ENVELOPE
Common Device Name
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
MEDTRONIC, INC.
8200 coral sea street ne
mounds view MN 55112
Manufacturer (Section G)
MEDTRONIC, INC.
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
gerard torenvliet
8200 coral sea st ne
mounds view, MN 55112-4391
7635269277
MDR Report Key21866900
Report Number2182208-2025-01955
Device Sequence Number14633117
Product Code FTL
UDI-Device Identifier00763000307875
UDI-Public00763000307875
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K130943
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Consumer,Health Professional
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 04/18/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date08/22/2025
Device Model NumberCMRM6122
Device Catalogue NumberCMRM6122
Device Lot NumberR241250
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/02/2025
Initial Report FDA Received Date04/18/2025
Date Device Manufactured08/27/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
407645 LEAD, 693565 LEAD
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age78 YR
Patient SexMale
Patient Weight93 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-